Neogen (NEOG) Financials: History & Chart

Neogen Corporation(NEOG)

Medical - Devices · Lansing, MI

$11.92-1.09 (-8.38%)

Delayed quote: Oct 6, 2026, 3:55 PM EDT

About Neogen Corporation

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

Lansing, MI

2,636 employees

www.neogen.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Mikhael Nassif

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended May 2026	Quarter ended Feb 2026	Quarter ended Nov 2025	Quarter ended Aug 2025	Quarter ended May 2025	Quarter ended Feb 2025	Quarter ended Nov 2024	Quarter ended Aug 2024
Revenue	870.38M	225.30M	211.20M	224.69M	209.19M	225.46M	220.98M	231.26M	216.96M
Cost of Goods Sold	461.93M	117.50M	112.20M	118.01M	114.22M	132.60M	134.01M	141.53M	130.53M
Gross Profit	408.45M	107.80M	99.00M	106.68M	94.97M	92.86M	86.97M	89.73M	86.44M
Gross Profit Margin	46.9%	47.8%	46.9%	47.5%	45.4%	41.2%	39.4%	38.8%	39.8%
Total Operating Expenses	430.12M	104.70M	102.30M	112.06M	111.06M	106.11M	74.98M	72.66M	77.78M
Research & Development	18.39M	4.90M	3.80M	4.56M	5.13M	6.31M	4.47M	5.11M	5.20M
Selling, General & Administrative	411.73M	99.80M	98.50M	107.50M	105.94M	99.80M	100.38M	104.32M	97.47M
Operating Income (EBIT)	-21.67M	3.10M	-3.30M	-5.38M	-16.09M	-13.25M	11.99M	17.07M	8.66M
Operating Margin	-2.5%	1.4%	-1.6%	-2.4%	-7.7%	-5.9%	5.4%	7.4%	4.0%
Income Before Tax (EBT)	-8.96M	-12.10M	-20.30M	-20.36M	43.81M	-631.20M	-9.73M	-476.57M	-15.61M
Interest Income	1.51M	N/A	N/A	592K	918K	644K	699K	774K	993K
Interest Expense	59.09M	13.90M	13.90M	14.85M	16.44M	17.13M	17.74M	18.14M	18.61M
Other Income/Expense	12.71M	-15.20M	-17.00M	-14.99M	59.90M	-617.95M	-21.71M	-493.64M	-24.27M
Net Income	-7.89M	-11.30M	-17.00M	-15.92M	36.34M	-612.20M	-10.96M	-456.28M	-12.61M
Income Tax Expense	-1.07M	-800K	-3.30M	-4.44M	7.47M	-19.01M	1.23M	-20.29M	-3.00M
Net Profit Margin	-0.9%	-5.0%	-8.0%	-7.1%	17.4%	-271.5%	-5.0%	-197.3%	-5.8%
EBITDA	100.23M	38.10M	25.62M	23.55M	12.96M	17.01M	41.36M	47.12M	38.46M
EBITDA Margin	11.5%	16.9%	12.1%	10.5%	6.2%	7.5%	18.7%	20.4%	17.7%
Depreciation & Amortization	121.90M	35.00M	28.92M	28.93M	29.05M	30.26M	29.37M	30.05M	29.80M
EPS Basic	-0.03	-0.05	-0.08	-0.07	0.17	-2.82	-0.05	-2.10	-0.06
EPS Diluted	-0.03	-0.05	-0.08	-0.07	0.17	-2.82	-0.05	-2.10	-0.06
Weighted Average Basic Shares	217.70M	217.70M	217.70M	217.41M	217.04M	217.04M	217.03M	216.81M	216.70M
Weighted Average Diluted Shares	217.70M	217.70M	217.70M	217.41M	217.04M	217.04M	217.03M	216.81M	216.70M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	05/31/2026	05/31/2025	05/31/2024	05/31/2023	05/31/2022	05/31/2021	05/31/2020	05/31/2019
Revenue	870.40M	894.66M	924.22M	822.45M	527.16M	468.46M	418.17M	414.19M
Cost of Goods Sold	461.90M	473.29M	461.59M	416.49M	284.15M	253.40M	221.89M	222.27M
Gross Profit	408.50M	421.38M	462.63M	405.95M	243.01M	215.06M	196.28M	191.92M
Gross Profit Margin	46.9%	47.1%	50.1%	49.4%	46.1%	45.9%	46.9%	46.3%
Total Operating Expenses	430.10M	411.96M	385.21M	368.44M	184.40M	140.89M	128.76M	123.83M
Research & Development	18.40M	21.09M	22.48M	26.04M	17.05M	16.25M	14.75M	12.80M
Selling, General & Administrative	411.70M	401.96M	382.76M	342.40M	167.35M	124.64M	114.01M	111.02M
Operating Income (EBIT)	-21.60M	9.42M	77.43M	37.52M	58.62M	74.17M	67.52M	68.09M
Operating Margin	-2.5%	1.1%	8.4%	4.6%	11.1%	15.8%	16.1%	16.4%
Income Before Tax (EBT)	-9.00M	-1.13B	-14.30M	-22.04M	60.21M	75.27M	72.31M	72.96M
Interest Income	N/A	3.11M	6.36M	3.17M	1.34M	1.69M	5.99M	4.68M
Interest Expense	57.60M	71.62M	73.39M	55.96M	72K	78K	N/A	N/A
Other Income/Expense	12.60M	-1.14B	-91.73M	-59.56M	1.59M	1.10M	4.78M	4.87M
Net Income	-7.90M	-1.09B	-9.42M	-22.87M	48.31M	60.88M	59.48M	60.18M
Income Tax Expense	-1.10M	-41.07M	-4.88M	828K	11.90M	14.39M	12.83M	12.78M
Net Profit Margin	-0.9%	-122.1%	-1.0%	-2.8%	9.2%	13.0%	14.2%	14.5%
EBITDA	100.30M	135.09M	198.65M	125.89M	82.31M	95.21M	85.92M	85.72M
EBITDA Margin	11.5%	15.1%	21.5%	15.3%	15.6%	20.3%	20.5%	20.7%
Depreciation & Amortization	121.90M	125.67M	121.23M	88.38M	23.69M	21.04M	18.40M	17.62M
EPS Basic	-0.04	-5.03	-0.04	-0.12	0.45	0.57	0.57	0.58
EPS Diluted	-0.04	-5.03	-0.04	-0.12	0.45	0.57	0.56	0.57
Weighted Average Basic Shares	217.50M	216.89M	216.48M	188.88M	107.68M	106.50M	105.10M	103.78M
Weighted Average Diluted Shares	217.50M	216.89M	216.48M	188.88M	108.02M	107.12M	105.72M	104.85M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.